Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
The Journal of the Association of Physicians of India|March 11, 2010
Heterotopic pancreas involving stomach and duodenumShubhangi V Agale, Vinayak G Agale, Rahul R Zode, et al.
Journal of Ayurveda and Integrative Medicine|March 25, 2022
Immunomodulatory activity of ethanol extract of Annona reticulata L. leaf in cultured immune cells and in Swiss albino miceSwagata Mazumdar, Amit K Ghosh, Suman Purohit, et al.
Indian Journal of Endocrinology and Metabolism|October 2, 2015
Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort studySunil Gupta, Kavita Gupta, R Ravi, et al.
Lung India : Official Organ of Indian Chest Society|April 3, 2023
Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence studyShambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Randomized, Double-blind, Phase III Trial of Lobeglitazone Add-on to Metformin in Type 2 Diabetes (SENSITIZE INDIA)Shashank Joshi, Monika Tandon, Rahul Kodgule, et al.
Frontiers in Endocrinology|December 5, 2024
Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic controlParamesh Shamanna, Shashank Joshi, Mohamed Thajudeen, et al.
Journal of Technology in Behavioral Science|April 4, 2022
High School Educator Training by Simulation to Address Emotional and Behavioral Concerns in School Settings: A Randomized StudyGlenn Albright, Mina Fazel, Nikita Khalid, et al.
The Journal of the Association of Physicians of India|October 11, 2024
Blue Index as a Comprehensive, Patient-centered Assessment of Care in Diabetic PatientsRupak Chatterjee, Arindam Naskar, Shambo Samrat Samajdar, et al.
Diabetes Technology & Therapeutics|October 22, 2013
A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI)Rajendrakumar H Jani, Vikas Pai, Pramod Jha, et al.
The Journal of the Association of Physicians of India|September 16, 2025
Ribavirin and IVIG Therapy for Severe hMPV Pneumonia: A Promising Therapeutic Approach for IndiaShambo S Samajdar, Rupak Chatterjee, Shatavisa Mukherjee, et al.
Pageof 14